~~<i id='B89B4F9FE7'><strike id='B89B4F9FE7'><tt id='B89B4F9FE7'><pre id='B89B4F9FE7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

focus

author：leisure time 2025-09-30 14:58:52 - browse：14444

WASHINGTON — Back in 1980, when the Food and Drug Administration approved the use of lead acetate in hair dyes, little was known about the way skin absorbs toxic chemicals.

The skin — and the scalp in particular — were considered tough barriers to break, and many public health officials believed that even if small amounts of lead got through, or were inhaled, it couldn’t really hurt anyone.

But in science, 37 years is an eon. So a coalition of environmental groups, academics, and consumer advocates is pushing FDA to take lead acetate off the market. It is now permitted as a color additive.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： The strategy behind pharma's lawsuits over drug pricing reform

entertainment

hotspot

focus

hotspot

focus

knowledge

JeromeDelay/APJusttwoyearsaftertheWorldHealthOrganization’shistoricrecommendationofthefirstmalariava

WSS

#NeedHerScience: shining a light on gender disparities in medicine

The battle over the Brookhaven Landfill on Long Island

The battle over the Brookhaven Landfill on Long Island

Why we need to separate burnout from moral injury in health care

#NeedHerScience: shining a light on gender disparities in medicine

Colonoscopy at 40? Study finds a possible benefit

explore

focus

entertainment

Drug repurposing or repositioning? The language matters

Ask STAT: What do you want to know about ChatGPT in medicine?

In Memoriam: Notable people who died in 2023

New oral drug delivery patch is modeled after octopus tentacles

Hollywood unions extend contract negotiations for actors

Colonoscopy at 40? Study finds a possible benefit

Jerome Adams on the need for new antivirals for Covid

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

At least 13 dead in Texas as scorching temps continue

With Roe v Wade overturned, abortion providers work to adapt

hotspot

Colonoscopy at 40? Study finds a possible benefit

With Roe v Wade overturned, abortion providers work to adapt

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

WHO recommends second malaria vaccine

Disclosing genetic information: not as worrisome as once feared

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

focus

hotspot

focus

knowledge